Sponsor

GlaxoSmithKline Biologicals

Belgium Rue De L'Institut 89, 1330, Belgium

About the sponsor

Research activity centres on RSV vaccines for older adults, solid organ transplant recipients, and adults at increased risk of respiratory disease, with attention to immune response, safety, and vaccine co-administration.

RSVPreF3 OA
RSV-A and RSV-B immunity
Transplant recipients
Co-administration with pneumococcal and COVID-19 vaccines

The sponsor also studies persistence of protection and revaccination strategies in populations with heightened vulnerability to lower respiratory tract disease.

About Specializations

GlaxoSmithKline Biologicals runs clinical trials in conditions such as Influenza, Varicella, Respiratory syncytial virus infection, Influenza immunisation, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

30 clinical trials

Influenza+1

Recruiting

Registered drugNo placebo

Efficacy and safety of the investigational mRNA influenza vaccine gskvx000000077430 (drug combination) in adults ≥ 65 years

Registered drugNo placebo

Belgium

Participants:65+ years · Healthy volunteers
Substances:INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED
Sponsor:GlaxoSmithKline Biologicals

Contact Research Centre

Herpes zoster

Recruiting

Registered drugNo placebo

Evaluating the effect of recombinant varicella zoster virus glycoprotein E vaccine on heart problems and dementia in adults aged 65 years or older with herpes zoster

Registered drugNo placebo

Denmark

Participants:65+ years · Healthy volunteers
Substances:Recombinant Varicella Zoster Virus Glycoprotein E
Sponsor:Gentofte Hospital

Contact Research Centre

Dementia

Recruiting

Registered drug

Evaluating the effect of recombinant varicella zoster virus glycoprotein E on the risk of dementia in adults aged 76 years and older

Registered drug

Finland

Participants:65+ years · Healthy volunteers
Substances:Recombinant Varicella Zoster Virus Glycoprotein E
Sponsor:GlaxoSmithKline Biologicals

Contact Research Centre

Respiratory syncytial virus infection

Recruiting

Registered drugNo placebo

Study of RSV vaccine immune response persistence and revaccination safety in adult lung and kidney transplant recipients

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
Sponsor:GlaxoSmithKline Biologicals

Contact Research Centre

Varicella

Recruiting

Registered drugNo placebo

Study of new chickenpox vaccine and measles-mumps-rubella vaccine given by intramuscular injection in healthy children aged 12 to 15 months

Registered drugNo placebo

Belgium

Participants:0–17 years · Healthy volunteers
Substances:GSKVX000000025896
Sponsor:GlaxoSmithKline Biologicals

Contact Research Centre

Varicella

Recruiting

Registered drugNo placebo

Study on the Immune Response and Safety of a New Varicella Vaccine (GSKVX000000025896) Compared to Varicella Virus Oka/Merck Strain in Healthy Children Aged 12-15 Months

Registered drugNo placebo

Belgium

Participants:0–17 years · Healthy volunteers
Substances:GSKVX000000025896
Sponsor:GlaxoSmithKline Biologicals

Contact Research Centre

Influenza+1

Not yet recruiting

Registered drugNo placebo

Study of the safety and immune response of gskvx000000077430 drug combination versus standard influenza vaccine in adults 18‑64 years

Registered drugNo placebo

Belgium

Participants:18–64 years · Healthy volunteers
Substances:INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED
Sponsor:GlaxoSmithKline Biologicals

Contact Research Centre

Varicella+5

Not yet recruiting

Registered drugNo placebo

Immune response and safety of investigational MMRV vaccine (GSKVX000000025896) drug combination compared with standard MMRV vaccine in healthy children 15 months to 6 years

Registered drugNo placebo

Germany

Participants:0–17 years · Healthy volunteers
Substances:GSKVX000000025896
Sponsor:GlaxoSmithKline Biologicals

Contact Research Centre

Varicella

Not yet recruiting

Registered drugNo placebo

Study on the Immune Response and Safety of a Second Dose of Investigational Varicella Vaccine (GSKVX000000025896) Compared to Varicella Virus Oka/Merck Strain in Healthy Children

Registered drugNo placebo

Denmark

Participants:0–17 years · Healthy volunteers
Substances:GSKVX000000025896
Sponsor:GlaxoSmithKline Biologicals

Contact Research Centre

Varicella immunisation+1

Not yet recruiting

Registered drugNo placebo

Study on Immune Response and Safety of Measles, Mumps, Rubella, and Varicella Vaccine in Healthy Children Aged 4 to 6 Years

Registered drugNo placebo

Latvia

Participants:0–17 years · Healthy volunteers
Substances:GSKVX000000025896
Sponsor:GlaxoSmithKline Biologicals

Contact Research Centre

Respiratory syncytial virus infection

Not recruiting

Registered drugNo placebo

Study on the Safety and Immune Response of RSVPreF3 OA Vaccine with PCV20 in Adults Aged 60 and Older with RSV Disease

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Pneumococcal Polysaccharide Serotype 1 Conjugated To Crm197 Adsorbed On Aluminium Phosphate
Sponsor:GlaxoSmithKline Biologicals

Contact Research Centre

Study on the Immune Response and Safety of RSVPreF3 OA Vaccine for Respiratory Syncytial Virus in Adults Aged 60 and Older

Not recruiting

Registered drugNo placebo

Study on the Immune Response and Safety of RSVPreF3 OA Vaccine for Respiratory Syncytial Virus in Adults Aged 60 and Older

Registered drugNo placebo

Finland

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
Sponsor:GlaxoSmithKline Biologicals

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →

About the sponsor

About Specializations

Ongoing trials

30 clinical trials

Influenza+1

Influenza+1

Varicella+5

Varicella immunisation+1

Are you running a clinical trial?

Prefer not to search? Our Concierge searches the trials for you.